May 20 (Reuters) - 3SBio Inc 1530.HK:
ENTERING INTO LICENSE AGREEMENT FOR PD-1/VEGF BISPECIFIC ANTIBODY (SSGJ-707) WITH PFIZER
POSSIBLE SUBSCRIPTION OF CERTAIN NUMBER OF NEW SHARES OF COMPANY BY PFIZER
TO RECEIVE $1.25 BILLION UPFRONT PAYMENT
PFIZER WILL SUBSCRIBE FOR US$100 MILLION DOLLARS WORTH OF ORDINARY SHARES OF CO
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.